Regeneron Pharmaceuticals Overview
Regeneron Pharmaceuticals Target Price
See Regeneron Pharmaceuticals's analyst price targets ($810) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$810.24
Average Target Price
$814.12
0.5% upside
0.5% upside26 analysts in the last 4 months
High: $1030 | Low: $641
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-14 | BernsteinJeffrey Walch | $756 |  6.7% downside |  |
| 2026-08-03 | Guggenheim | $1,030 | 27.1% upside | |
| 2026-07-31 | Robert W. Baird | $761 | 6.1% downside | |
| 2026-07-31 | RBC Capital | $737 | 9% downside | |
| 2026-07-31 | Cantor FitzgeraldCarter Gould | $795 | 1.9% downside | |
| 2026-07-31 | Wells Fargo | $750 | 7.4% downside | |
| 2026-07-31 | Morgan Stanley | $758 | 6.4% downside | |
| 2026-07-21 | GuggenheimYatin Suneja | $1,000 | 23.4% upside | |
| 2026-07-09 | Piper SandlerBiren Amin | $854 | 5.4% upside | |
| 2026-07-08 | Morgan StanleyTerence Flynn | $730 | 9.9% downside | |
| 2026-07-07 | Truist Financial | $769 | 5.1% downside | |
| 2026-07-06 | HSBC | $800 | 1.3% downside | |
| 2026-07-06 | Cantor Fitzgerald | $750 | 7.4% downside | |
| 2026-05-19 | Canaccord GenuityJohn Newman | $875 | 8% upside | |
| 2026-05-18 | Evercore ISI | $825 | 1.8% upside | |
| 2026-05-18 | Wolfe ResearchAlexandria Hammond | $860 | 6.1% upside | |
| 2026-05-18 | Leerink PartnersMarket Perform | $641 | 20.9% downside | |
| 2026-05-18 | Truist Financial | $778 | 4% downside | |
| 2026-05-18 | BMO Capital | $730 | 9.9% downside | |
| 2026-05-18 | RBC Capital | $707 | 12.7% downside | |
| 2026-05-18 | Piper Sandler | $855 | 5.5% upside | |
| 2026-05-01 | GuggenheimYatin Suneja | $995 | 22.8% upside | |
| 2026-04-30 | Truist Financial | $796 | 1.8% downside | |
| 2026-04-30 | Morgan StanleyTerence Flynn | $788 | 2.7% downside | |
| 2026-04-30 | Barclays | $917 | 13.2% upside | |
| 2026-04-22 | Raymond JamesChris Raymond | $910 | 12.3% upside | |
| 2026-04-10 | Morgan Stanley | $796 | 1.8% downside | |
| 2026-04-08 | Bernstein | $921 | 13.7% upside | |
| 2026-03-09 | Truist FinancialGreg Renza | $818 | 1% upside | |
| 2026-03-06 | BarclaysEliana Merle | $923 | 13.9% upside | |
| 2026-03-02 | RBC CapitalBrian Abrahams | $765 | 5.6% downside | |
| 2026-02-09 | Guggenheim | $975 | 20.3% upside | |
| 2026-02-02 | Robert W. BairdBrian Skorney | $742 | 8.4% downside | |
| 2026-02-02 | Tudor PickeringWilliam Pickering | $925 | 14.2% upside | |
| 2026-02-02 | Cantor FitzgeraldCarter Gould | $800 | 1.3% downside | |
| 2026-02-02 | Oppenheimer | $865 | 6.8% upside | |
| 2026-02-01 | Morgan StanleyTerence Flynn | $769 | 5.1% downside | |
| 2026-01-30 | Raymond James | $870 | 7.4% upside | |
| 2026-01-27 | Tudor PickeringWilliam Pickering | $916 | 13.1% upside | |
| 2026-01-27 | Bernstein | $916 | 13.1% upside | |
| 2026-01-27 | RBC CapitalBrian Abrahams | $745 | 8.1% downside | |
| 2026-01-22 | Evercore ISI | $875 | 8% upside | |
| 2026-01-08 | Goldman Sachs | $914 | 12.8% upside | |
| 2025-12-17 | Leerink PartnersAndrew Berens | $873 | 7.7% upside | |
| 2025-12-12 | Morgan StanleyTerence Flynn | $768 | 5.2% downside | |
| 2025-12-10 | HSBC | $985 | 21.6% upside | |
| 2025-12-04 | Canaccord Genuity | $1,057 | 30.5% upside | |
| 2025-12-04 | BMO CapitalEvan Seigerman | $850 | 4.9% upside | |
| 2025-11-24 | Scotiabank | $770 | 5% downside | |
| 2025-11-24 | Truist Financial | $798 | 1.5% downside | |